ACLARION INC (ACON)
US6551872012 - Common Stock
Wednesday's session: top gainers and losers
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Which stocks are experiencing notable movement on Wednesday?
Which stocks are experiencing notable movement on Wednesday?
The market is filled with gapping stocks in Wednesday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Gap analysis on 2024-12-11: gap up and gap down stocks in today's session.
Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash
Article Focuses on how Leading Physicians are Incorporating Nociscan Into Their Clinical Practices for Chronic Low Back Pain Patients MAGNETOM Flash is a...
Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st
Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit
Fireside Chat Scheduled for 2:00 PM ET on October 15, 2024 BROOMFIELD, Colo., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the...
Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes
Modic Changes (MC) are MRI Findings Associated With Endplate Damage, Neoinnervation, and Chronic Low Back Pain (cLBP) MR Spectroscopy (MRS) Measurement of...
Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Aclarion Provides Corporate Update on Nociscan AI Technology Milestones
Successful milestones achieved and upcoming include peer-reviewed publications, commercial agreements, and payer coverage decisions Progressing with...
Aclarion Provides Corporate Update on Nociscan AI Technology Milestones
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Aclarion, Inc.’s (NASDAQ: ACON) Emerging Role in the Back Pain Management Sector
Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial
Initial LIFEHAB Enrolled Patients Receive Nociscan Exams to Help Evaluate How Biomarkers in the Discs of the Lumbar Spine Correspond With Treatment...
Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial
Initial LIFEHAB Enrolled Patients Receive Nociscan Exams to Help Evaluate How Biomarkers in the Discs of the Lumbar Spine Correspond With Treatment Response
Aclarion Launches Surgeon Partnership to Apply Nociscan’s AI Technology to Personal Injury and Workers Compensation Market
Justin Kubeck, M.D. of Ocean Pain and Spine in Toms River, NJ Will Lead a Statewide Network of Providers That Use Nociscan to Better Serve This Important...
Aclarion Launches Surgeon Partnership to Apply Nociscan's AI Technology to Personal Injury and Workers Compensation Market
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey
CLUE is a Multi-center Trial to Identify how Often Nociscan’s AI Data Changes the Initial Treatment Plan for Patients With Chronic Low Back Pain Dr....
Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan’s AI Generated Biomarker Data Changes Surgical Treatment Plans
Surgeons Will Determine Their Surgical Treatment Plan Before Nociscan and Report on How Often the Surgical Plan Changes After Receiving Nociscan Data ...
Aclarion to Present at August 20th Virtual Investor Summit Microcap Event
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Aclarion to Present at August 20th Virtual Investor Summit Microcap Event
BROOMFIELD, CO, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company...
ACON Stock Earnings: Aclarion Beats EPS, Misses Revenue for Q2 2024
ACON stock results show that Aclarion beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
ACON Stock Earnings: Aclarion Beats EPS, Misses Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Aclarion (NASDAQ:ACON) just reported results for the second quarter of 2024.Acl...
Aclarion Announces First Commercial Agreement in Michigan
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Aclarion Announces First Commercial Agreement in Michigan
Sheridan Community Hospital is the First Healthcare Institution in Michigan With Nociscan Agreement Expands Nociscan Access to John Keller, MD, a Leading...
Aclarion Hits Another Key Milestone by Adding Vitality - Third Major Payer to Cover Nociscan in Greater UK
Vitality is a top 4 Provider of Private Medical Insurance in the UK.Aclarion now has Payer Coverage From 3 of the 4 Largest Private Health Insurers in the...
Aclarion Hits Another Key Milestone by Adding Vitality - Third Major Payer to Cover Nociscan in Greater UK
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Aclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UK
Aviva is a Top 4 Provider of Private Medical Insurance in the UK By Joining AXA, Approximately 45% of Patients With Private Insurance Now Have Access to...
Aclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UK
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UK
AXA is the 2nd Largest Provider of Private Medical Insurance in the UK Payer Coverage is the Most Important Catalyst Aclarion can Achieve to Drive Volume...
Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UK
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater London
Established in 1932, the London Clinic is the UK’s Most Renowned Independent, Private Hospital Payment to Aclarion for Each Nociscan is Being Increased...
Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater London
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Aclarion Receives Notice of Allowance for US Patent to Support Further Optimization of Accuracy and Reliability in the Nociscan Solution
Notice of Allowance is for the 23rd US Patent to be Awarded to Aclarion
Aclarion Receives Notice of Allowance for US Patent to Support Further Optimization of Accuracy and Reliability in the Nociscan Solution
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Aclarion Announces Updated Product Release That Enhances User-Experience, Scalability, and Security for Nociscan Solution
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Aclarion Announces Updated Product Release That Enhances User-Experience, Scalability, and Security for Nociscan Solution
Nociscan is the first augmented intelligence platform to measure pain biomarkers in the lumbar spine.
ACON Stock Earnings: Aclarion Reported Results for Q1 2024
Aclarion just reported results for the first quarter of 2024.
ACON Stock Earnings: Aclarion Reported Results for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Aclarion (NASDAQ:ACON) just reported results for the first quarter of 2024.Acla...